Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MDR1 polymorphism influences the outcome of multiple myeloma patients.

British journal of haematology - 1 Jun 2007

Buda Gabriele, Maggini Valentina, Galimberti Sara, Martino Alessandro, Giuliani Nicola, Morabito Fortunato, Genestreti Giovenzio, Iacopino Pasquale, Rizzoli Vittorio, Barale Roberto, Rossi Anna M, Petrini Mario

Abstract excerpt

The multidrug resistance gene (MDR1) has been reported to be an additional prognostic factor in acute myeloid leukaemia patients. This study evaluated the prognostic role of MDR1 in the outcome of 115 multiple myeloma patients treated with DAV (dexamethasone, doxorubicin [adryamicin] and vincrist...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dexamethasone

Share to Doxorubicin

Share to Genes, MDR

Share to Multiple Myeloma

Share to Survival Analysis

Share to Vincristine

Source

Identifiers

PMID: 17488488
DOI: 10.1111/j.1365-2141.2007.06605.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17488488-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MDR1 polymorphism influences the outcome of multiple myeloma patients.PMID 17488488Read ↗

MDR1 polymorphisms affect the outcome of Chinese multiple myeloma patients.Semantic proximity Read ↗

MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma.Semantic proximity Read ↗

MDR1 diplotypes as prognostic markers in multiple myeloma.Semantic proximity Read ↗

Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia.Semantic proximity Read ↗

Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1/ABCB1) and risk of multiple myeloma.Semantic proximity Read ↗

VEGF, VEGFR2 and GSTM1 polymorphisms in outcome of multiple myeloma patients treated with thalidomide-based regimens.Semantic proximity Read ↗

Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population.Semantic proximity Read ↗

The impact of matched and mismatched donor-recipient genotypes for MDR1 polymorphisms (G2677TA, C1236T and C3435T) on the outcomes of patients after allogeneic haematopoietic stem cell transplantation.Semantic proximity Read ↗

Multidrug resistance 1 (MDR1/ABCB1) gene polymorphism (rs1045642 C > T) and susceptibility to multiple myeloma: a systematic review and meta-analysis.Semantic proximity Read ↗

The association between multidrug resistance-1 gene polymorphisms and outcomes of allogeneic HLA-identical stem cell transplantation.Semantic proximity Read ↗

Multi-drug transporter MDR1 gene polymorphism and prognosis in adult acute lymphoblastic leukemia.Semantic proximity Read ↗

[Correlation between MDR1 genetic polymorphism and prognosis in acute myeloid leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.